×

Vaccine purchasing strategy helps Serbia lead European vaccination

Vaccine purchasing strategy helps Serbia lead European vaccination 5

Vaccine purchasing strategy helps Serbia lead European vaccination

As a series of Covid-19 vaccines are launched, countries large and small are making efforts to speed up vaccination campaigns.

Like other countries, Covid-19 overshadowed Serbia’s efforts to return to normal life for a year.

However, the average number of daily infections decreased sharply in April, to 2,500 thanks to the vaccine.

The main challenge for all developing countries today is to ensure sufficient quantities of vaccines.

Therefore, Serbia’s strategy is to seek diverse supply sources based on trade and diplomatic relationships.

People line up to get vaccinated against Covid-19 in Belgrade, Serbia, March 28.

Traditionally, Serbia’s foreign policy has been characterized by a balance between the West and the East.

However, as the number of nCoV infections is increasing, Covax does not provide a clear vaccine distribution time, Serbia uses traditional diplomatic relations with Russia and China to ensure supply.

President Aleksandar Vučić declared in January: `Today, obtaining nuclear weapons is easier than the Covid-19 vaccine.`

Since then, Serbia has reinforced its stockpile with tens of thousands of doses of Russia’s Sputnik V, signing an agreement to produce the Sputnik V vaccine in the country from May 20.

Serbia is even strong enough to start implementing its own vaccine diplomacy, providing thousands of doses to neighboring countries such as North Macedonia, Montenegro or Republika Srpska.

In the midst of an extremely tight market, when 130 countries have not yet started vaccination, Serbia emerged as the `leader` by taking advantage of geopolitical competition.

Vuk Vuksanovic, a researcher at the London School of Economics and the Belgrade Center for Security Policy, said: `Vaccine procurement is a symbol of Serbia’s foreign policy. Balancing between the West and non-Western countries

Serbia was the first European country to approve the Sinopharm vaccine, receiving one million doses at Belgrade airport on January 16.

Post Comment